aLaboratory for Interventional and Experimental Endoscopy InExEn, Gastroenterology, University of Würzburg, Würzburg, Germany
bDepartment of Community Medicine, National Research Center in Complementary and Alternative Medicine, NAFKAM, UiT, The Arctic University of Norway, Tromsø, Norway
cSurgeon, Bergisch Gladbach, Germany
Log in to MyKarger to check if you already have access to this content.
Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more
CHF 38.00 *
EUR 35.00 *
USD 39.00 *
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price. Rent/Cloud Rent for 48h to view Buy Cloud Access for unlimited viewing via different devices Synchronizing in the ReadCube Cloud Printing and saving restrictions apply Rental: USD 8.50* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication DetailsFirst-Page Preview
Received: January 05, 2022
Accepted: April 25, 2022
Published online: May 23, 2022
Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 3
ISSN: 0012-2823 (Print)
eISSN: 1421-9867 (Online)
For additional information: https://www.karger.com/DIG
AbstractBackground: The Gastrointestinal Quality of Life Index (GIQLI) is a well-established instrument for the assessment of quality of life (QOL) in gastrointestinal (GI) diseases. The purpose of this literature review was to investigate QOL by means of GIQLI in patients with gastroesophageal reflux disease (GERD) prior to any interventional therapy. There are several reports on GIQLI data; however, comparisons from different countries and/or different GERD cohorts assessing the same disease have to date not been conducted. Methods: The GIQLI uses 36 items around 5 dimensions (GI symptoms [19 items], emotional dimension [5 items], physical dimension [7 items], social dimension [4 items], and therapeutic influences [1 item]). A literature search was conducted on the application of GIQLI in GERD patients prior to interventional therapy using reports in PubMed. Data on the mean GIQLI as well as index data for the 5 dimensions as originally validated were extracted from the published patient cohorts. A comparison with the normal healthy control group from the original publication of the GIQLI validation conducted by Eypasch was performed. Data are presented descriptively as GIQLI points as well as a reduction from 100% maximum possible index points (max 144 index points = highest QOL). Results: In total, 77 abstracts from studies using the GIQLI on patients with GERD were identified. After screening for content, 21 publications were considered for further analysis. Ten studies in GERD patients comprised complete calculations of all dimensions and were included in the analysis. Data from 1,682 study patients were evaluated with sample sizes ranging from 33 to 568 patients (median age of 789 females and 858 males: 51.8 years). The median overall GIQLI for the patient group was 91.7 (range 86–102.4), corresponding to 63.68% of the maximum GIQLI. The dimensions with the largest deviation from the respective maximum score were the physical dimension (55% of maximum) followed by the emotional dimension (60% of maximum). In summary, the GIQLI level in GERD cohorts was reduced to 55–75% of the maximum possible index. Conclusions: Severe GERD causes substantial reductions in the patient’s QOL. The level of GIQLI can carry between different studied GERD cohorts from different departments and countries. GIQLI can be used as an established tool to assess the patient’s condition in various dimensions.
© 2022 S. Karger AG, Basel
References Boeckxstaens GEE. Review: the pathophysiology of gastro-esophageal reflux disease. Aliment Pharmacol Ther. 2007;26:149–60. Fuchs KH, Lee AM, Breithaupt W, Varga G, Babic B, Horgan S. Pathophysiology of GERD: which factors are important? Transl Gastroenterol Hepatol. 2021 Oct 25;6:53. Broderick R, Fuchs KH, Breithaupt W, Varga G, Schulz T, Babic B, et al. Clinical presentation of GERD: a Prospective Study on symptom diversity and modification of questionnaire application. Dig Dis. 2020;38(3):188–195. Vakil N, van Zanten SV, Kahrilas PJ, Dent J, Jones R; Global Consensus Group. The montreal definition and classification of GERD: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–20. Gyawali CP, Kahrilas PJ, Savarino E, Zerbib F, Mion F, Smout AJPM, et al. Modern diagnosis of GERD: the Lyon consensus. Gut. 2018 Jul;67(7):1351–62. Velanovich V. Comparison of generic (SF-36) versus disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease. J Gastrointest Surg. 1998 Mar–Apr;2(2):141–5. Kamolz T, Bammer T, Wykypiel H Jr, Pasiut M, Pointner R. Quality of life and surgical outcome after laparoscopic Nissen and Toupet fundoplication: one-year follow-up. Endoscopy. 2000 May;32(5):363–8. Eypasch E, Wood-Dauphinée S, Williams JI, Ure B, Neugebauer E, Troidl H. Der Gastrointestinale Lebensqualitätsindex (GLQI). Ein klinimetrischer Index zur Befindlichkeitsmessung in der gastroenterologischen Chirurgie [The gastrointestinal quality of life index. A clinical index for measuring patient status in gastroenterologic surgery]. Chirurg. 1993 Apr;64(4):264–74. [German]. Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmülling C, Neugebauer E, et al. Gastrointestinal quality of life index: development, validation and application of a new instrument. Br J Surg. 1995 Feb;82(2):216–22. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European organization for research and treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 Mar 3;85(5):365–76. Sailer M, Bussen D, Debus ES, Fuchs KH, Thiede A. Quality of life in patients with benign anorectal disorders. Br J Surg. 1998 Dec;85(12):1716–9. Granderath FA, Kamolz T, Schweiger UM, Pasiut M, Wykypiel H Jr, Pointner R. Quality of life and symptomatic outcome three to five years after laparoscopic Toupet fundoplication in gastroesophageal reflux disease patients with impaired esophageal motility. Am J Surg. 2002 Feb;183(2):110–6. Schwenk W, Neudecker J, Haase O, Raue W, Strohm T, Müller JM. Comparison of EORTC quality of life core questionnaire (EORTC-QLQ-C30) and gastrointestinal quality of life index (GIQLI) in patients undergoing elective colorectal cancer resection. Int J Colorectal Dis. 2004 Nov;19(6):554–60. Fein M, Fuchs KH, Thalheimer A, Freys SM, Heimbucher J, Thiede A. Long-term benefits of Roux-en-Y pouch reconstruction after total gastrectomy: a randomized trial. Ann Surg. 2008 May;247(5):759–65. Bell RCW, Freeman K, Heidrick R, Ayazi S. Transoral incisionless fundoplication demonstrates durability at up to 9 years. Therap Adv Gastroenterol. 2021 Apr 16;14:17562848211004827. Slim K, Bousquet J, Kwiatkowski F, Lescure G, Pezet D, Chipponi J. Première validation de la version française de l'index de qualité de vie pour les maladies digestives (GIQLI) [First validation of the French version of the gastrointestinal quality of life index (GIQLI)]. Gastroenterol Clin Biol. 1999 Jan;23(1):25–31. [French]. Yeung SM, Shiu AT, Martin CR, Chu KM. Translation and validation of the Chinese version of the gastrointestinal quality of life index in patients with gastric tumor. J Psychosom Res. 2006 Oct;61(4):469–77. Lien HH, Huang CC, Wang PC, Chen YH, Huang CS, Lin TL, et al. Validation assessment of the Chinese (Taiwan) version of the gastrointestinal quality of life index for patients with symptomatic gallstone disease. J Laparoendosc Adv Surg Tech A. 2007 Aug;17(4):429–34. Sandblom G, Videhult P, Karlson BM, Wollert S, Ljungdahl M, Darkahi B, et al. Validation of gastrointestinal quality of life index in Swedish for assessing the impact of gallstones on health-related quality of life. Value Health. 2009 Jan–Feb;12(1):181–4. Watadani Y, Ohge H, Hashimoto Y, Kondo N, Sakashita Y, Uemura K, et al. Validating the Japanese version of the gastrointestinal quality of life index (GIQLI) questionnaire. Ann Gastroenterol Surg. 2020 Jul 18;4(5):597–601. Posegger KR, Maeda CT, Taveira JP, Caetano EM Jr, Ferraz MB, de Brito Rocha MJA, et al. Brazilian-Portuguese validation assessment of the gastrointestinal quality of life index for patients after laparoendoscopic cholecystectomy. J Laparoendosc Adv Surg Tech A. 2022 Feb;32(2):125–31. Poves Prim I, Macías GJ, Cabrera Fraga M, Situ L, Ballesta López C. Quality of life in morbid obesity. Rev Esp Enferm Dig. 2005 Mar;97(3):187–95. [English, Spanish] Yu PJ, Tsou JJ, Lee WJ, Lee KT, Lee YC. Impairment of gastrointestinal quality of life in severely obese patients. World J Gastroenterol. 2014 Jun 14;20(22):7027–33. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Open Med. 2009;3(3):e123–30. Dallemagne B, Weerts J, Markiewicz S, Dewandre JM, Wahlen C, Monami B, et al. Clinical results of laparoscopic fundoplication at ten years after surgery. Surg Endosc. 2006 Jan;20(1):159–65. Díaz de Liaño A, Yárnoz C, Artieda C, Flores L, Garde C, Romeo I, et al. Gastroesophageal reflux: prevalence of psychopathological disorders and quality of life implications. Dis Esophagus. 2006;19(5):373–6. Wang W, Huang MT, Wei PL, Lee WJ. Laparoscopic antireflux surgery for the elderly: a surgical and quality-of-life study. Surg Today. 2008;38(4):305–10. Fein M, Bueter M, Thalheimer A, Pachmayr V, Heimbucher J, Freys SM, et al. Ten-year outcome of laparoscopic antireflux surgery. J Gastrointest Surg. 2008 Nov;12(11):1893–9. Borie F, Glaise A, Pianta E, Veyrac M, Millat B. Long-term quality-of-life assessment of gastrointestinal symptoms before and after laparoscopic Nissen fundoplication. Gastroenterol Clin Biol. 2010 Aug–Sep;34(6–7):397–402. Fuchs KH, Breithaupt W. Benigne Erkrankungen des Ösophagus. Refluxkrankheit, diffuser Ösophagusspasmus, Achalasie [Benign esophageal disorders. Gastroesophageal reflux disease, diffuse esophageal spasm, achalasia]. Chirurg. 2011 Mar;82(3):271–9; quiz 280–1. [German]. Fuchs KH, Breithaupt W, Varga G, Babic B, Schulz T, Meining A. Primary laparoscopic fundoplication in selected patients with gastroesophageal reflux disease. Dis Esophagus. 2021 May 18;35(1):doab032. Heikkinen TJ, Haukipuro K, Bringman S, Ramel S, Sorasto A, Hulkko A. Comparison of laparoscopic and open Nissen fundoplication 2 years after operation. A prospective randomized trial. Surg Endosc. 2000 Nov;14(11):1019–23. Slim K, Bousquet J, Kwiatkowski F, Lescure G, Pezet D, Chipponi J. Quality of life before and after laparoscopic fundoplication. Am J Surg. 2000 Jul;180(1):41–5. Zügel N, Jung C, Bruer C, Sommer P, Breitschaft K. A comparison of laparoscopic Toupet versus Nissen fundoplication in gastroesophageal reflux disease. Langenbecks Arch Surg. 2002 Jan;386(7):494–8. Ciovica R, Gadenstätter M, Klingler A, Lechner W, Riedl O, Schwab GP. Quality of life in GERD patients: medical treatment versus antireflux surgery. J Gastrointest Surg. 2006 Jul–Aug;10(7):934–9. Yano F, Sherif AE, Turaga K, Stadlhuber RJ, Tsuboi K, Ramaswamy S, et al. Gastrointestinal quality of life in patients after anti reflux surgery. Dis Esophagus. 2009;22(2):177–84. Lippmann QK, Crockett SD, Dellon ES, Shaheen NJ. Quality of life in GERD and Barrett’s esophagus is related to gender and manifestation of disease. Am J Gastroenterol. 2009 Nov;104(11):2695–703. Zhu JC, Becerril G, Marasovic K, Ing AJ, Falk GL. Laparoscopic repair of large hiatal hernia: impact on dyspnoea. Surg Endosc. 2011 Nov;25(11):3620–6. Luketina RR, Koch OO, Köhler G, Antoniou SA, Emmanuel K, Pointner R. Obesity does not affect the outcome of laparoscopic antireflux surgery. Surg Endosc. 2015 Jun;29(6):1327–33. Weitzendorfer M, Spaun GO, Antoniou SA, Witzel K, Emmanuel K, Koch OO. Clinical feasibility of a new full-thickness endoscopic plication device (GERDx™) for patients with GERD: results of a prospective trial. Surg Endosc. 2018 May;32(5):2541–9. Fuchs HF, Babic B, Fuchs KH, Breithaupt W, Varga G, Musial F. Do patients with gastroesophageal reflux disease and somatoform tendencies benefit from antireflux surgery? World J Gastroenterol. 2019 Jan 21;25(3):388–97. Khoma O, Burton L, Falk MG, Van der Wall H, Falk GL. Predictors of reflux aspiration and laryngo-pharyngeal reflux. Esophagus. 2020 Jul;17(3):355–62. Jobe BA, Richter JE, Hoppo T, Peters JH, Bell R, Dengler WC, et al. Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the esophageal diagnostic advisory panel. J Am Coll Surg. 2013 Oct;217(4):586–97. Bradley LA, Richter JE, Pulliam TJ, Haile JM, Scarinci IC, Schan CA, et al. The relationship between stress and symptoms of gastroesophageal reflux: the influence of psychological factors. Am J Gastroenterol. 1993;88(1):11–9. Johnston BT, Lewis SA, Love AH. Stress, personality and social support in gastro-oesophageal reflux disease. J Psychosom Res. 1995;39(2):221–6. Tack J, Caenepeel P, Arts J, Lee KJ, Sifrim D, Janssens J. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut. 2005;54(10):1370–6. Savarino E, Pohl D, Zentilin P, Dulbecco P, Sammito G, Sconfienza L, et al. Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut. 2009;58(9):1185–91. Fuchs KH, Musial F, Ulbricht F, Breithaupt W, Reinisch A, Babic B, et al. Foregut symptoms, somatoform tendencies, and the selection of patients for antireflux surgery. Dis Esophagus. 2017 Jul 1;30(7):1–10. Wuestenberghs F, Juge M, Melchior C, Desprez C, Leroi AM, Gourcerol G. Association between symptoms, quality of life, and gastric emptying in dyspeptic patients. J Neurogastroenterol Motil. 2019 Oct 30;25(4):534–43. Velanovich V. The development of the GERD-HRQL symptom severity instrument. Dis Esophagus. 2007;20(2):130–4. Nicolau AE, Crăciun M, Zota R, Kitkani A. Quality of life after laparoscopic fundoplication for gastroesophageal reflux disease. Preliminary Study. Chirurgia. 2013 Nov–Dec;108(6):788–93. Bona D, Saino G, Mini E, Lombardo F, Panizzo V, Cavalli M, et al. Magnetic sphincter augmentation device removal: surgical technique and results at medium-term follow-up. Langenbecks Arch Surg. 2021 Nov;406(7):2545–51. Article / Publication DetailsFirst-Page Preview
Received: January 05, 2022
Accepted: April 25, 2022
Published online: May 23, 2022
Number of Print Pages: 8
Number of Figures: 2
Number of Tables: 3
ISSN: 0012-2823 (Print)
eISSN: 1421-9867 (Online)
For additional information: https://www.karger.com/DIG
Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
留言 (0)